Corium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex™ Donepezil Transdermal System
MENLO PARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced …